Eight EU States Post $8.3 Bil. Diabetes Drug Spend - SmithKline Study
Eight EU countries spent $8.3 bil. on type 2 diabetes drugs in 1998, according to initial results from a SmithKline Beecham-sponsored study presented to the European Association for the Study of Diabetes in Brussels Sept. 29.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth